chrX-134475194-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000194.3(HPRT1):c.148G>C(p.Ala50Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A50V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000194.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPRT1 | NM_000194.3 | c.148G>C | p.Ala50Pro | missense_variant | 3/9 | ENST00000298556.8 | NP_000185.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPRT1 | ENST00000298556.8 | c.148G>C | p.Ala50Pro | missense_variant | 3/9 | 1 | NM_000194.3 | ENSP00000298556.7 | ||
HPRT1 | ENST00000462974.5 | n.306G>C | non_coding_transcript_exon_variant | 3/8 | 3 | |||||
HPRT1 | ENST00000475720.1 | n.106G>C | non_coding_transcript_exon_variant | 2/8 | 3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Nephrolithiasis/nephrocalcinosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2019 | The p.A50P variant (also known as c.148G>C), located in coding exon 3 of the HPRT1 gene, results from a G to C substitution at nucleotide position 148. The alanine at codon 50 is replaced by proline, an amino acid with highly similar properties. In one study, this alteration was detected in an individual with HGprt-related neurological dysfunction (HND). In addition, authors used fibroblast cultures to show that both Hprt and Hprt enzyme activity for this alteration was significantly reduced (less than 2%) compared to normal controls (Fu R et al. Mol. Genet. Metab., 2015 Jan;114:55-61). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at